151 · 1 · Common · 2023
The raw price over time, with any graded series laid over the same axis — the comparison a grading decision turns on.
Premium10 graded series can be laid over this line — see what the slab did while the raw price moved.Unlock
Every graded price published, next to how many copies exist at that grade.
| Grade | Market | vs raw | Population | Pop higher |
|---|---|---|---|---|
| ▶PSA 10 | $212 unverified | 813.8× | 716 | 0 |
| ▶PSA 9 | $39.32 unverified | 151.2× | 988 | 716 |
| ▶PSA 8 | $12.76 | 49.1× | 178 | 1,707 |
| ▶PSA 7 | $33.03 | 127.0× | 23 | 1,885 |
| Grade | Market | vs raw | Population | Pop higher |
|---|---|---|---|---|
| ▶BGS 9.5 | $15.00 | 57.7× | — | — |
| ▶BGS 9 | $14.00 | 53.8× | — | — |
| ▶BGS 8.5 | $8.50 | 32.7× | — | — |
| Grade | Market | vs raw | Population | Pop higher |
|---|---|---|---|---|
| ▶CGC 10 | $25.81 | 99.3× | — | — |
| ▶CGC 9.5 | $14.67 | 56.4× | — | — |
| ▶CGC 9 | $6.19 unverified | 23.8× | — | — |
| ▶CGC 8.5 | $14.01 | 53.9× | — | — |
| ▶CGC 8 | $26.73 | 102.8× | — | — |
| ▶CGC 7.5 | $1.00 unverified | 3.8× | — | — |
| ▶CGC 5.5 | $37.12 | 142.8× | — | — |
A model's opinion, not investment advice.